ABVX

AS OF

Jan 14 closing price

Price

$125.01

Change

+$5.37 (+4.49%)

Capitalization

9.5B

67 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ABVX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Abivax SA (ABVX) Earnings Date & Reports

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABVX is expected to report earnings to fall 72.47% to -68 cents per share on March 23

Q4'25

Est.

$-0.68

Q3'25

Missed

by $1.79

Q2'25

Missed

by $0.70

Q1'25

Missed

by $0.29

Q4'24

Beat

by $0.50

The last earnings report on December 15 showed earnings per share of -247 cents, missing the estimate of -68 cents. With 1.47M shares outstanding, the current market capitalization sits at 9.50B.

View a ticker or compare two or three

Compare

ABVX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABVX showed earnings on December 15, 2025. You can read more about the earnings report here.

View AI-Driven Trading for ABVX

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

7-11 boulevard Haussmann

Phone

+33 153830963

Employees

Web

https://www.abivax.com